Cara Mathews, MD, spoke with CancerNetwork® about research examining dostarlimab vs doxorubicin for patients with mismatch repair–deficient endometrial cancers.
Cara Mathews, MD
Advertisement
Articles by Cara Mathews, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Delays Decision on Subcutaneous Isatuximab in Multiple Myeloma
2
TERN-701 Earns FDA Breakthrough Therapy Designation in Ph+ CML
3
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
4
Exploring and Managing Gastrointestinal-Related CAR T-Cell Lymphomas
5